Results 71 to 80 of about 22,136 (209)

Escitalopram: efficacy and tolerability in the treatment of depression

open access: yes, 2002
Escitalopram is a new antidepressant drug, available for clinical use in many countries. This review describes the properties of escitalopram, summarizes the results of randomized controlled trials, and suggests that escitalopram has advantages over ...
Baldwin, David S.
core   +1 more source

Serotonin Signaling Pathway Modulation Affects Retinal Neuron Survival in Experimental Model of Retinal Ischemia

open access: yesLife
Serotonin is a key neurotransmitter involved in visual processing. Selective serotonin reuptake inhibitors (SSRIs), such as Escitalopram, enhance serotonergic transmission and exert neuroprotective effects.
Joanna Machowicz   +7 more
doaj   +1 more source

Identification and Treatment of Anorexia Nervosa in Women With Perimenopause

open access: yesJournal of Midwifery &Women's Health, EarlyView.
Abstract Disordered eating is a common problem that midwives will encounter as frontline primary care providers. Anorexia nervosa (AN) is a form of disordered eating that results in chronic starvation state, creating significant risk of morbidity and mortality to the patient. AN is traditionally considered a disorder of adolescence and young adulthood;
Janell Senda   +2 more
wiley   +1 more source

Double blind, randomised trial to compare efficacy of escitalopram versus citalopram for interferon induced depression in hepatitis C patients

open access: yesContemporary Clinical Trials Communications, 2020
Objectives: The objective of the study was to compare the two antidepressant drugs citalopram and escitalopram on the basis of efficacy in depressed patients of Hepatitis C patients receiving interferons.
Uzma Shakeel   +4 more
doaj   +1 more source

Mean prolactin levels before PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).

open access: yes, 2013
Mean prolactin levels before PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).
Sollip Kim (491807)   +1 more
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke

open access: yes, 2018
Recent studies have demonstrated that antidepressants could enhance functional recovery via neuroplasticity beyond solely treating depression. However, since Koreans typically show a greater aversion to seeking psychiatric care than citizens of Western ...
Jarim Kim, Yerim Kim
core   +1 more source

Theories and Practices on Developing Various Models of Betel Quid Cessation in Taiwan

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective This review examines the development and outcomes of Taiwan's betel quid cessation models over two decades. Betel quid, the world's fourth most used psychoactive substance, receives far less cessation attention than tobacco. Methods We present a narrative synthesis of program evaluations and national implementation data from Taiwan ...
Ming‐Shinn Lee, Yi‐Jung Tsai
wiley   +1 more source

The therapeutic potential of escitalopram in the treatment of panic disorder

open access: yes, 2007
Mark H Townsend, Erich J ConradDepartment of Psychiatry, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USAAbstract: Panic disorder is a chronic and disabling condition that is often accompanied by other ...
Mark H Townsend, Erich J Conrad
core  

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy